Shanghai OPM Biosciences Co., Ltd. (SHA:688293)

Shanghai OPM Biosciences Revenue

Shanghai OPM Biosciences had revenue of 271.53M CNY in the quarter ending June 30, 2026, with 188.65% growth. This brings the company's total for the last twelve months to 630.86M, up 90.37% year-over-year. In the year 2025, Shanghai OPM Biosciences had annual revenue of 354.91M with 19.40% growth. That makes Shanghai OPM Biosciences the 23,095th largest company in the world by revenue and 4,192nd in China.

• Revenue (ttm): 630.86M
• Revenue Growth: +90.37%
• P/S Ratio: 12.76
• Revenue / Employee: 6.18M
• Employees: 102
• Market Cap: 8.05B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Culture Medium Products 300.45M 84.8%
• CDMO 53.98M 15.2%

By Geography

Chart

• China 244.92M 69.1%
• Overseas 109.51M 30.9%

Fiscal year ended Dec 31, 2025 See the full Shanghai OPM Biosciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	354.91M	57.67M	19.40%
Dec 31, 2024	297.24M	54.12M	22.26%
Dec 31, 2023	243.12M	-51.24M	-17.41%
Dec 31, 2022	294.37M	81.68M	38.41%
Dec 31, 2021	212.68M	87.71M	70.19%

Data Source: S&P Global Market Intelligence Last updated: Aug 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error